CytomX Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
CytomX Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2014 to Q3 2024.
  • CytomX Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $70K, a 19.5% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $70K -$17K -19.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $76K -$15K -16.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $80K +$53K +196% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $83K +$56K +207% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $87K -$808K -90.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $91K -$804K -89.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $27K -$875K -97% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $27K -$874K -97% Dec 31, 2022 10-K 2024-03-11
Q3 2022 $895K -$7K -0.78% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $895K -$6K -0.67% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $902K -$1.34M -59.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $901K -$1.27M -58.5% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $902K -$477K -34.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $901K -$478K -34.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $2.25M +$867K +62.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $2.17M +$157K +7.79% Dec 31, 2020 10-K/A 2023-03-27
Q3 2020 $1.38M +$4K +0.29% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.38M +$4K +0.29% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.38M +$4K +0.29% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.02M +$640K +46.5% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $1.38M $0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.38M $0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.38M $0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $1.38M +$20K +1.48% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $1.38M -$1.7M -55.2% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $1.38M -$1.87M -57.6% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $1.38M -$1.38M -50.1% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $1.36M -$1.62M -54.4% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $3.07M +$2.85M +1259% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $3.24M +$2.97M +1109% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $2.75M +$2.44M +791% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $2.97M +$2.61M +717% Dec 31, 2016 10-K 2018-03-07
Q3 2016 $226K -$3.12M -93.2% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $268K Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $309K Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $364K -$128K -26% Dec 31, 2015 10-K 2017-03-02
Q3 2015 $3.34M Sep 30, 2015 10-Q 2015-11-23
Q4 2014 $492K Dec 31, 2014 10-K 2016-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.